Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL6354312 | 0.95 | SLC34A1 (0.54) | — | |
| Phosphoric Acid SCHEMBL5803230 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL133050 | 0.95 | SLC34A1 (0.64) | — | |
| Phosphoric Acid SCHEMBL3164904 | 0.91 | SLC34A1 (0.50) | — | |
| Phosphoric Acid SCHEMBL25422657 | 0.90 | SLC34A1 (0.58) | — | |
| Phosphoric Acid SCHEMBL18245505 | 0.90 | — | — | |
| Phosphoric Acid SCHEMBL13735124 | 0.90 | SLC34A1 (0.58) | — | |
| Phosphoric Acid SCHEMBL3390891 | 0.90 | — | — | |
| Phosphoric Acid SCHEMBL20540375 | 0.90 | SLC34A1 (0.73) | — | |
| Phosphoric Acid SCHEMBL4001661 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113827614-B | Method for preparing medicinal mixture, medicinal mixture obtained by method and medical application of medicinal mixture | 厦门大学 | 2025-02-11 | — | — | CN | claimed |
| WO-2024081871-A1 | SHIGELLA MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION AND FUSION PROTEINS THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2024-04-18 | — | — | WO | claimed |
| WO-2024081906-A1 | A MAPS VACCINE TARGETING GROUP B STREPTOCOCCUS (GBS) | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2024-04-18 | — | — | WO | claimed |
| WO-2024081929-A1 | MULTIPLE ANTIGEN PRESENTING SYSTEM (MAPS) CROSS-LINKED USING A BIFUNCTIONAL FUSION PROTEIN AND ITS USE IN VACCINES | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2024-04-18 | — | — | WO | claimed |
| EP-4327876-A2 | IMMUNOGENIC COMPOSITIONS | Affinivax, Inc. (US) | 2024-02-28 | — | — | EP | claimed |
| CN-117339558-A | Preparation of active carbon/expanded graphite composite material and adsorption application of volatile organic compounds thereof | 燕山大学 | 2024-01-05 | — | — | CN | claimed |
| US-20230414740-A1 | IMMUNOGENIC COMPOSITIONS | AFFINIVAX, INC. | 2023-12-28 | — | — | US | claimed |
| US-20230390375-A1 | MULTIVALENT PNEUMOCOCCAL VACCINES | AFFINIVAX, INC. | 2023-12-07 | — | — | US | claimed |
| EP-3641828-B1 | IMMUNOGENIC COMPOSITIONS | AFFINIVAX INC (US) | 2023-11-22 | — | — | EP | claimed |
| WO-2023192997-A2 | IMMUNOGENIC COMPOSITIONS FOR B-CELL RECALL RESPONSE TO A POLYSACCHARIDE ANTIGEN | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-10-05 | — | — | WO | claimed |
| CN-106085968-B | Mad dog inactivated vaccine of a kind of mink puppet and its preparation method and application | 中国农业科学院特产研究所 | 2019-06-18 | — | — | CN | claimed |
| CN-109153780-A | The end Alkanizing catalyst of polyalkylene glycol and the polyalkylene glycol end alkylation procedure for utilizing it | 韩国NH化学品有限公司 | 2019-01-04 | — | — | CN | claimed |
| WO-2018237221-A1 | IMMUNOGENIC COMPOSITIONS | NOSOCOMIAL VACCINE CORPORATION (US) | 2018-12-27 | — | — | WO | claimed |
| US-20180154337-A1 | Catalyst for alkylation of polyalkylene glucol and alkylation method using the same | NH CHEMICALS (KR) | 2018-06-07 | — | — | US | claimed |
| CN-102939105-B | Immunogenic compositions and related methods | 赛诺菲巴斯德有限公司 | 2016-11-16 | — | — | CN | claimed |
| CN-106085968-A | A kind of mink pseudorabies inactivated vaccine and its production and use | 中国农业科学院特产研究所 | 2016-11-09 | — | — | CN | claimed |
| US-6310016-B1 | Reacting a mixture of one or more fats or fatty acids with phosphoric acid and an alkaline aluminum containing material to obtain aluminum hydroxide-phosphate complex and soap, adding water, converting the product into bars | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2001-10-30 | — | — | US | claimed |
| US-20010031711-A1 | Detergent bar composition and manufacturing process comprising colloidal aluminium hydroxide phosphate complex | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO | 2001-10-18 | — | — | US | claimed |
| WO-2001042419-A1 | IMPROVED DETERGENT BAR COMPOSITION AND MANUFACTURING PROCESS | UNILEVER PLC (GB) | 2001-06-14 | — | — | WO | claimed |
| WO-2001042413-A1 | DETERGENT BAR COMPOSITION AND PROCESS FOR ITS MANUFACTURE | UNILEVER N.V. (NL) | 2001-06-14 | — | — | WO | claimed |